Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP652267.RAcpCVh1Aj5vLU2mgXnaL0yexICoEG02pZ768PAjhfEYY130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP652267.RAcpCVh1Aj5vLU2mgXnaL0yexICoEG02pZ768PAjhfEYY130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP652267.RAcpCVh1Aj5vLU2mgXnaL0yexICoEG02pZ768PAjhfEYY130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP652267.RAcpCVh1Aj5vLU2mgXnaL0yexICoEG02pZ768PAjhfEYY130_provenance.
- NP652267.RAcpCVh1Aj5vLU2mgXnaL0yexICoEG02pZ768PAjhfEYY130_assertion description "[To evaluate the effect of shortened duration of pegylated interferon (PEG-IFN) and ribavirin (RIB) treatment on sustained virological response (SVR) rates in treatment-naomicronve patients with chronic hepatitis due to genotype 2 or 3 hepatitis C virus (HCV) infection and high pre-treatment viral load (>800,000 IU/mL).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP652267.RAcpCVh1Aj5vLU2mgXnaL0yexICoEG02pZ768PAjhfEYY130_provenance.
- NP652267.RAcpCVh1Aj5vLU2mgXnaL0yexICoEG02pZ768PAjhfEYY130_assertion evidence source_evidence_literature NP652267.RAcpCVh1Aj5vLU2mgXnaL0yexICoEG02pZ768PAjhfEYY130_provenance.
- NP652267.RAcpCVh1Aj5vLU2mgXnaL0yexICoEG02pZ768PAjhfEYY130_assertion SIO_000772 18227568 NP652267.RAcpCVh1Aj5vLU2mgXnaL0yexICoEG02pZ768PAjhfEYY130_provenance.
- NP652267.RAcpCVh1Aj5vLU2mgXnaL0yexICoEG02pZ768PAjhfEYY130_assertion wasDerivedFrom befree-2016 NP652267.RAcpCVh1Aj5vLU2mgXnaL0yexICoEG02pZ768PAjhfEYY130_provenance.
- NP652267.RAcpCVh1Aj5vLU2mgXnaL0yexICoEG02pZ768PAjhfEYY130_assertion wasGeneratedBy ECO_0000203 NP652267.RAcpCVh1Aj5vLU2mgXnaL0yexICoEG02pZ768PAjhfEYY130_provenance.
- befree-2016 importedOn "2016-02-19" NP652267.RAcpCVh1Aj5vLU2mgXnaL0yexICoEG02pZ768PAjhfEYY130_provenance.